Show simple item record

dc.contributor.authorConseil exécutif, 120
dc.coverage.spatialGenèveen
dc.date.accessioned2012-03-14T06:39:59Z
dc.date.available2012-03-14T06:39:59Z
dc.date.issued2007
dc.identifier.govdocEB120/33
dc.identifier.urihttp://www.who.int/iris/handle/10665/22068
dc.descriptionConseil exécutif Cent vingtième session, Point 9.1 de l’ordre du jour provisoire, 6 p.en
dc.language.isofren
dc.publisherOrganisation mondiale de la Santéen
dc.subjectPharmaceutical productsen
dc.subjectVaccinesen
dc.subjectFood safetyen
dc.subject.meshBiological Productsen
dc.subject.meshVaccinesen
dc.subject.meshDrug Residuesen
dc.subject.meshFood Contaminationen
dc.subject.meshVeterinary Drugsen
dc.subject.meshPsychotropic Drugsen
dc.titleComités d’experts et groupes d’étude : rapport du Secrétariaten
dc.typeGoverning body documentsen
dc.subject.meshqualifierstandardsen
dc.subject.meshqualifiertoxicityen
dc.subject.meshqualifieradverse effectsen
who.relation.languageVersion10665/21971en
who.relation.languageVersion10665/25548en
who.relation.languageVersion10665/24793en
who.relation.languageVersion10665/24201en
who.relation.languageVersion10665/23372en
who.relation.languageVersion10665/69562en


Files in this item

Thumbnail

This item appears in the following Collection(‎s)‎

  • EB120
    22-30 January 2007

Show simple item record